On the stock market since 2021, it operates in the everyday-essentials business. It has 6 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 24% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executives buying with their own money is usually read as confidence in the company’s future.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
An investor who bought at the very peak is down 69% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $2.8M a year. A small number, but proof the product has real buyers.
There is $9.5M in the vault; even if every debt were paid off, $9.2M would remain.
Over the last 12 months, company executives reported 13 buys and 6 sells. Management buying with its own money is usually read as a good sign.
A loss of $3.1M against $2.8M in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
On our five-subject report card, VAPE sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: VAPE is a high-risk stock — not yet profitable, and its future rides on its product catching on.